*2.8.2.2 Bifidobacterium and necrotizing enterocolitis*

Following regular treatment of B. breve M-16 V, recent research found a decreased incidence of necrotizing enterocolitis in premature infants [80]. Administration of B. breve M-16 V in conjunction with breast-feeding was demonstrated to be related with a decreased incidence of necrotizing enterocolitis in neonates born before 34 weeks gestation, and, while not statistically significant, a lower incidence of this disorder was found for neonates born at a gestation age of less than 28 weeks [80].
